Piper Acquisition III, Inc.Arkson Neutraceuticals Corp. • November 26th, 2010 • Blank checks
Reference is hereby made to that certain Contribution Agreement entered by and between Arkson Neutraceuticals Corp. (“Arkson”), David Roff (“Roff”) and Piper Acquisition III, Inc. (“Piper”) dated November 4, 2010 (the “Agreement”). In consideration of the payment of $7,500 by Piper to Arkson, the letter agreement shall serve to amend the following provisions of the Agreement:
